UNITED STATES
                                 SECURITIES AND EXCHANGE COMMISSION
                                              WASHINGTON, D.C. 20549


     DIVISION OF
CORPORATION FINANCE


                                                               April 24, 2019

  By E-Mail

  Aneliya S. Crawford, Esq.
  Schulte Roth & Zabel LLP
  919 Third Avenue
  New York, NY 10022

          Re:     MiMedx Group, Inc.
                  Soliciting Materials filed pursuant to Rule 14a-12 on April
11 and 16, 2019
                  Filed by Parker H. Petit, David J. Furstenberg, and Shawn P.
George
                  File No. 001-35887

  Dear Ms. Crawford:

         We have reviewed your filings and have the following comments. In some
of our
  comments, we may ask you to provide us with information so we may better
understand your
  disclosure.

         Please respond to this letter by amending your filings, by providing
the requested
  information, or by advising us when you will provide the requested response.
If you do not
  believe our comments apply to your facts and circumstances or do not believe
an amendment is
  appropriate, please tell us why in your response.

         After reviewing any amendment to your filings and the information you
provide in
  response to these comments, we may have additional comments.

  Soliciting Materials filed April 11, 2019

  1.      We note the domain name of your website. Please tell us whether you
have considered
          changing the domain name to ensure that security holders do not
confuse your website
          with a company website, which may currently occur.

  2.      We note your references to the company's board and management
performance, to
          security holders having been "left in the dark," the company's value
having "significantly
          dropped," the absence of "much needed accountability," and "failure
to ensure competent
          leadership." Please revise your disclosure to clarify that Mr. Petit
was a part of the board
          and management for several years ending in 2018 and address what
role, if any, Mr. Petit
          had in such areas.

  3.      On a related note, to ensure that shareholders have complete
information, please revise
          your disclosure relating to the end of Mr. Petit's tenure with the
board and company
 Aneliya S. Crawford, Esq.
Schulte Roth & Zabel LLP
April 24, 2019
Page 2

       management to clarify that the board and compensation committee of the
board
       determined that the termination of his employment was "for cause." Also,
clarify that the
       company is currently in the process of restating its financial
statements for several years
       during which Mr. Petit was chairman and chief executive officer of the
company.

4.     We note that in Mr. Petit's biography you indicate that Mr. Petit was,
at least in part,
       responsible for growing the company from a start-up stage "to the 5th
fastest growing
       public company in 2017." Please provide us support for your assertion.

5.     Please clarify in the biography for Mr. George, if true, that Mr. George
is Mr. Petit's
       personal attorney.

6.     Refer to the screen shots of the page captioned "Nominees" on your
website. Revise your
       disclosure to clarify how any of your nominees is able to "understand
the majority of the
       legal issues and accounting issues associated with the decisions that
have been made by
       the current Board since June 2018" given that none of your nominees
appear to have had
       access to board deliberations or meetings.

7.     Each statement or assertion of opinion or belief must be clearly
characterized as such,
       and a reasonable factual basis must exist for each such opinion or
belief. Support for
       opinions or beliefs should be self-evident, disclosed in the proxy
statement or provided to
       the staff on a supplemental basis. With a view toward revised
disclosure, provide support
       for your statement that the current board "has made numerous decisions,
that...have been
       devastating to the Company."

Soliciting Materials filed April 16, 2019

8.     We note your disclosure that you "call[] out suspicious timing, lack of
disclosure and
       leadership as confirmed by negative market reaction." Note that you must
avoid issuing
       statements that directly or indirectly impugn the character, integrity
or personal
       reputation or make charges of illegal, improper or immoral conduct
without factual
       foundation. Provide us supplementally, or disclose, the factual
foundation for the
       assertions referenced above. In this regard, note that the factual
foundation for such
       assertion must be reasonable. Refer to Rule 14a-9.

9.     With a view toward revised disclosure, please tell us whether the timing
of your press
       release on April 11, 2019 (during trading hours) may have had an effect
on the stock
       market price independent of the company's press release (made after
trading hours).

10.    Please provide us support for your assertion that the company "needs to
borrow
       money..." and that such borrowing will have a dilutive effect on current
shareholders.
       We note, as above, that none of your nominees appear to have had access
to board
       deliberations or meetings.
 Aneliya S. Crawford, Esq.
Schulte Roth & Zabel LLP
April 24, 2019
Page 3

11.    Each statement or assertion of opinion or belief must be clearly
characterized as such,
       and a reasonable factual basis must exist for each such opinion or
belief. Support for
       opinions or beliefs should be self-evident, disclosed in the proxy
statement or provided to
       the staff on a supplemental basis. With a view toward revised
disclosure, provide support
       for your disclosure that the "choice of interim management...has cost
all shareholders
       substantially."

        We remind you that the filing persons are responsible for the accuracy
and adequacy of
their disclosures, notwithstanding any review, comments, action or absence of
action by the staff

       Please direct any questions to me at (202) 551-3619.

                                                            Sincerely,

                                                            /s/ Daniel F.
Duchovny
                                                            Daniel F. Duchovny
                                                            Special Counsel
                                                            Office of Mergers
and Acquisitions